References
- Farup P G, Larsen S, Ulshagen K, Osnes M. Ranitidine for non-ulcer dyspepsia. A clinical study of the symptomatic effect of ranitidine and a classification and characterization of the responders to treatment. Scand J Gastroenterol 1991; 26: 1209–16
- Gotthard R, Bodemar G, Brodin U, Jönsson KÅ. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988; 23: 7–18
- Johannessen T, Fjösne U, Kleveland P M, Halvorsen T, Kristensen P, Løge I, et al. Cimetidine responders in non-ulcer dyspepsia. Scand J Gastroenterol 1988; 23: 327–36
- Johannessen T, Kristensen P, Petersen H, Fosstvedt D, Løge I, Kleveland P M, et al. The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled single-subject trials. Scand J Gastroenterol 1991; 26: 974–80
- Johannessen T, Petersen H, Kristensen P, Fosstvedt D, Kleveland P M, Dybdahl J, et al. Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials. Scand J Gastroenterol 1992; 27: 189–95
- Saunders J HB, Oliver R J, Higson DL. Dyspepsia: incidence of non-ulcer disease in a controlled trial of ranitidine in general practice. Br Med J 1986; 292: 665–8
- Nyrén O, Adami H O, Bates S, Bergström R, Gustavsson S, Lööf L, et al. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986; 314: 339–43
- Hansen J M, Bytzer P, Schaffalitzky de Muckadell OB. Placebo-controlled trial of cisapride and nizatidine in unselected patients with non-ulcer dyspepsia. Gastroenterology 1994; 106: 994, Suppl A89
- Jamieson J R, Stein H J, De Meester T R, Bonavina L, Schwizer W, Winder R A, et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992; 87: 1102–11
- Larsen S, Farup P, Flaten O, Osnes M. The multi-crossover model for classifying patients as responders to a given treatment. Scand J Gastroenterol 1991; 26: 763–70
- Pfeiffer A, Aronbayev J, Schmidt T, Wendl B, Pehl C, Kaess H. Gastric emptying, esophageal 24-hour pH and gastric potential difference measurements in non-ulcer dyspepsia. Gastroenterol Clin Biol 1992; 16: 395–400
- Klauser A G, Voderholzer W A, Knesewitsch P A, Schindlbeck N E, Miiller-Lissner SA. What is behind dyspepsia?. Dig Dis Sci 1993; 38: 147–54
- Klauser A G, Schindlbeck N E, Müller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205–8
- Talley N J, Weaver A L, Tesmer D L, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 1993; 105: 1378–86
- De Boer W A, Tytgat G NJ. Review article: drug therapy for reflux oesophagitis. Aliment Pharmacol Ther 1994; 8: 147–57
- Robinson M G, Orr W C, McCallum R, Nardi R. Do. endoscopic findings influence response to H2 antagonist therapy for gastroesophageal reflux disease? Am J Gastroenterol 1987; 82: 519–22
- Kamad D R, Abraham P, Rathod N M, Nazareth HM. Test for H2-antagonist response in non-ulcer dyspepsia. Lancet 1990; 335: 657–8
- George A A, Tsuchiyose M, Dooley CP. Sensitivity of the gastric mucosa to acid and duodenal contents in patients with non-ulcer dyspepsia. Gastroenterology 1991; 101: 3–6
- Misra S P, Broor SL. Is gastric acid responsible for the pain in patients with essential dyspepsia?. J Clin Gastroenterol 1990; 12: 624–7